| ²é¿´: 1427 | »Ø¸´: 38 | |||||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||||||
[½»Á÷]
¡¾2015-03-27¡¿¡¾EI/ISTP¡¿SCIÆÚ¿¯ Õ÷¸å£¨¶àģ̬·Ö×ÓÓ°Ïñ£©IF£º2.7
|
|||||||
SCIÆÚ¿¯ Õ÷¸å£¨¶àģ̬·Ö×ÓÓ°Ïñ£©IF£º2.7 BioMed Research InternationalÊÇSCIÊÕ¼ÆÚ¿¯£¬Ö÷Òª¿¯ÔØÃæÏòҽѧÓëÉúÃü¿ÆÑ§ÁìÓò·½ÃæµÄÑо¿¼°½øÕ¹¡£×îÐÂJCRÓ°ÏìÒò×ÓΪ2.7 ±¾ÆÚÌØ¼µÄÖ÷ÌâµÄ¶àģ̬·Ö×ÓÓ°Ïñ£¬½Ø¸åʱ¼äΪ2015Äê3ÔÂ27ÈÕ£¬Í¶¸å¾ßÌåÒªÇóºÍÒ³ÃæÈçÏ£ºhttps://www.hindawi.com/journals/bmri/si/538402/cfp/ Multimodality Molecular Imaging Call for Papers Multimodal molecular imaging can offer a synergistic improvement of diagnostic ability over a single imaging modality. Recent development of hybrid imaging systems has profoundly impacted the pool of available multimodal imaging probes. A combination of multifunctional molecular probes such as biomolecules, polymers, and nanoparticles continues to increase functionality for in vivo multimodal imaging and therapeutic agents. In this special issue, we take a great interest in studies on multimodal molecular imaging. Particularly, papers that deal with functional investigations of multimodal molecular imaging are welcome. Cutting-edge reviews relevant to this topic are also considered. This special issue will bring our communities the most recent ideas and advances in this field. Potential topics include, but are not limited to: Multimodality molecular imaging and targeted therapy Nanotechnology for multimodality molecular imaging In vivo application for multimodal molecular imaging of tumor Authors can submit their manuscripts via the Manuscript Tracking System at https://mts.hindawi.com/submit/jo ... ular.imaging/mica/. Manuscript Due Friday, 27 March 2015 First Round of Reviews Friday, 19 June 2015 Publication Date Friday, 14 August 2015 Lead Guest Editor Xin Zhou, Wuhan Institute of Physics and Mathematics, Wuhan, China Guest Editors Michael T. McMahon, Johns Hopkins University, Baltimore, USA Shaoqun Zeng, Huazhong University of Science and Technology, Wuhan, China [ Last edited by Paulwolf on 2015-3-7 at 08:41 ] |
» ²ÂÄãϲ»¶
²ÄÁÏÇóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó×Ü·Ö298·Ö£¬Ç°Èý¿Æ223·Ö
ÒѾÓÐ4È˻ظ´
086502»¯Ñ§¹¤³Ì342Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
352·Ö »¯¹¤Óë²ÄÁÏ
ÒѾÓÐ5È˻ظ´
085602 »¯¹¤×¨Ë¶ 338·Ö Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
0856²ÄÁÏ»¯¹¤µ÷¼Á ×Ü·Ö330
ÒѾÓÐ10È˻ظ´
330Ò»Ö¾Ô¸Öйúº£Ñó´óѧ »¯Ñ§¹¤³Ì 085602 ÓжÁ²©ÒâÔ¸ Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤·½Ïò336·Ö
ÒѾÓÐ6È˻ظ´
²ÄÁÏÇóµ÷¼ÁÒ»Ö¾Ô¸¹þ¹¤´ó324
ÒѾÓÐ6È˻ظ´
085600 286·Ö ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
×ÊÔ´Óë»·¾³×¨Ë¶
+1/73
Çൺ¿Æ¼¼´óѧÉúÎ﹤³ÌѧԺÕе÷¼Á˶ʿÑо¿Éú
+1/71
ºÏ·Ê¹¤¿Æ211Ë®Àû¹¤³Ìµ÷¼ÁÕÐÉú
+1/54
×ø±ê¹ãÖÝ£¬Õ÷Å®ÓÑ
+2/50
Î÷¾©Ñ§ÔºÍÁľˮÀû 2026 ¼¶Ñо¿ÉúÕÐÉú
+2/44
°²»Õ¹¤³Ì´óѧ»¯Ñ§Óë»·¾³¹¤³ÌѧԺ¶ÔÍâÕÐÊÕ2026¼¶µ÷¼Á˶ʿÑо¿Éú
+1/36
¡¾·ÖÏí¡¿ÕÐÊÕ08¹¤Ñ§Ë¶Ê¿£¨ÒªÇó¹ý¹ú¼ÒÏߣ©
+1/34
¼ÃÄÏ´óѧˮÀûÓë»·¾³Ñ§ÔºÕÔÑÞÏÀ½ÌÊÚ¼ò½é
+1/32
°Ä´óÀûÑÇÀ¥Ê¿À¼´óѧ»¯¹¤Ñ§ÔºÕÐÊÕÈ«½±²©Ê¿Éú2Ãû
+1/26
˫һÁ÷´óÑ§ÏæÌ¶´óѧ¡°»¯¹¤¹ý³ÌÄ£ÄâÓëÇ¿»¯¡±¹ú¼ÒµØ·½ÁªºÏ¹¤³ÌÑо¿ÖÐÐÄÕÐÊÕ¸÷À಩ʿÉú
+1/16
¡¾2026µ÷¼Á¡¿ÄÏ·½¿Æ¼¼´óѧ-ÉîÛÚÀí¹¤´óѧ-ÖпÆÔº ÁªÅà086000ÃâÒß·½Ïò(26.9Èëѧ)
+1/11
Alicat ²ãÁ÷ѹ²îÖÊÁ¿Á÷Á¿¿ØÖÆÆ÷ÔÚÐÂÐ͹è̼¸º¼«Á÷»¯´²µÄÓ¦ÓÃ- °¬Àï¿¨ÌØ£¨Alicat£©
+3/10
¸Û¿Æ´ó£¨¹ãÖÝ£©ÕÐÊÕ¹âѧ´«¸ÐÆ÷£¬¼¯³Éµç·Éè¼Æ£¬Ò½Ñ§Ó°ÏñÉ豸ÒÔ¼°¿É´©´÷É豸·½ÏòµÄ²©Ê¿
+1/9
¿ÎÌâ×éÕÐÊÕרҵ´úÂë08¿ªÍ·µÄѧ˶£¡
+1/9
ÄÏ¿ª´óѧ»·¾³¿ÆÑ§Ó빤³ÌѧԺÍõöνÌÊÚ¿ÎÌâ×éÕÐÊÕÉêÇ뿼ºËÖÆ²©Ê¿Éú
+1/8
ÈýÏ¿´óѧ ¼ÆËãÁ¦Ñ§¿ÎÌâ×éÕÐÊÕµ÷¼Á
+1/7
½ËտƼ¼´óѧ»úе¹¤³ÌѧԺº£Ñó×°±¸·ÂÉú¿ÎÌâ×éÕÐÉú¼ò½é
+1/5
CD40L¿¹ÌåÈçºÎµ÷¿ØÃâÒßÓ¦´ð£¿
+1/3
ÉϺ£Ê¦·¶´óѧÓлú»¯Ñ§×¨ÒµÑо¿ÉúÕÐÉú
+1/2
Ïã¸Û´óѧ »¯Ñ§Ïµ ²©ºóÕÐÆ¸
+1/1
26Â¥2015-03-19 06:52:35
¼òµ¥»Ø¸´
numerical11Â¥
2015-03-07 20:19
»Ø¸´
ÓÄÈôÜ·Ü·(½ð±Ò+1): лл²ÎÓë


















»Ø¸´´ËÂ¥